WILSON – Reckitt plans to double its investment in a developing Wilson manufacturing facility to $400 million and expand the building to 544,000 square feet.

The consumer health and hygiene company announced the North Carolina expansion Wednesday as part of a phased U.S. investment program of up to $600 million covering the Wilson facility and a commercial and research campus in New Jersey. The national figure is not a North Carolina-only investment.

Reckitt said the Wilson site will become its largest over-the-counter manufacturing facility in the United States. Additional funding will expand production capacity for Mucinex tablets and liquids and increase production of Move Free supplements. The company expects the facility to open in the first half of 2027.

The Wall Street Journal reported that the revised plan adds 234,000 square feet to the existing 310,000-square-foot building, bringing the total to 544,000 square feet. Reckitt expects the facility to make more than 80% of its Mucinex products in the United States.

North Carolina’s 2024 project announcement said Reckitt would invest $145.59 million and create 289 jobs in Wilson. Reckitt later described its initial company commitment as $200 million. The new announcement doubles that company investment, but it did not provide a revised Wilson employment target or say whether state or local incentive terms will change.

The current milestone is an expanded investment and production plan for a facility that is still being developed. The site is not yet open or operational.

Sources